Press Release
October 30, 2018
DSM informs market on the completion of the sale of Fibrant’s caprolactam business to Highsun
DSM anticipates receiving about €200 million in cash in various steps in 2018 and 2019.
Heerlen, NL, 30 Oct 2018 11:00 CET
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, informs its stakeholders that Fibrant Holding BV has completed the sale of Fibrant BV and 60% of the shares of Fibrant China to the Highsun Holdings Group Ltd.
Through the joint venture Chemicalnvest, DSM and CVC Capital Partners indirectly owned 35% and 65% respectively of the shares of Fibrant BV and in the same proportion 60% of the shares in Fibrant China. The transaction was announced on 17 May 2018. DSM anticipates receiving about €200 million in cash related to this transaction, which is expected to be received in various steps in 2018 and 2019.
DSM still owns 19% in AOC Aliancys (the composite resins joint venture with CVC) and 35% in AnQore (the acrylonitrile joint venture with CVC).